You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Environmental Exposure Chamber

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
May 5, 2022

Allergic Rhinitis, Allergy to Pollen, Rhinoconjunctivitis Trial in Strasbourg (Exposure to , Exposure to allergen)

Completed
  • Allergic Rhinitis
  • +2 more
  • Exposure to placebo
  • Exposure to allergen
  • Strasbourg, Grand Est, France
    Alyatec
Jun 8, 2021

Allergic Rhinitis Trial in Mississauga (Azelastine HCl (BAYR9258), Placebo)

Completed
  • Allergic Rhinitis
  • Azelastine hydrochloride (BAYR9258)
  • Placebo
  • Mississauga, Ontario, Canada
    Cliantha Research
Mar 10, 2022

Birch Pollen Allergy Trial in Mississauga (DM-101PX, Placebo to Match DM-101PX)

Recruiting
  • Birch Pollen Allergy
  • DM-101PX
  • Placebo to Match DM-101PX
  • Mississauga, Ontario, Canada
    Cliantha Research
Sep 18, 2023

Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A: Azelastine HCl 0.15% nasal spray (Azelair), Treatment B: Placebo

Recruiting
  • Seasonal Allergic Rhinitis
  • Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)
  • +2 more
  • Mississauga, Ontario, Canada
    Cliantha Research
Nov 6, 2023

Seasonal Allergic Rhinitis Trial (Mometasone Furoate Nasal Spray, Placebo)

Completed
Has Results
  • Seasonal Allergic Rhinitis
  • Mometasone Furoate Nasal Spray
  • Placebo
  • (no location specified)
Feb 7, 2022

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
Jan 3, 2022

Asthma, Allergy Trial in Strasbourg (Active intense Pure Air XL air cleaner, Placebo Intense Pure Air XL air cleaner)

Completed
  • Asthma
  • Allergy
  • Active intense Pure Air XL air cleaner
  • Placebo Intense Pure Air XL air cleaner
  • Strasbourg, Bas-Rhin, France
    Alyatec
Dec 14, 2020

Allergic Asthma, Allergy, Allergy to Cats Trial in Strasbourg (Exposure to Placebo, Exposure to dose A and dose B of cat

Completed
  • Allergic Asthma
  • +2 more
  • Exposure to Placebo
  • +2 more
  • Strasbourg, Grand Est, France
    Alyatec
Dec 16, 2020

Allergic Rhinitis Due to Grass Pollen Trial in Strasbourg (Grass Pollen Allergen Exposure)

Completed
  • Allergic Rhinitis Due to Grass Pollen
  • Grass Pollen Allergen Exposure
  • Strasbourg, France
    ALYATEC
Oct 27, 2023

Allergic Asthma, Allergy to House Dust, Allergy Trial in Strasbourg (Exposure to in EEC, Exposure to three concentrations of

Completed
  • Allergic Asthma
  • +2 more
  • Exposure to placebo in EEC
  • +2 more
  • Strasbourg, Grand Est, France
    Alyatec
Dec 10, 2020

Seasonal Allergic Rhinitis Trial in Mississauga (Treatment A (Dymista): Fixed drug combination of azelastine HCl and fluticasone

Completed
  • Seasonal Allergic Rhinitis
  • Treatment A (Dymista): Fixed drug combination of azelastine hydrochloride and fluticasone propionate nasal spray at Visit 3
  • +3 more
  • Mississauga, Ontario, Canada
    Cliantha Research
Feb 11, 2022

COPD, Healthy Trial in Hannover (Exposure to clean air, Exposure to urban air)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Healthy
  • Exposure to clean air
  • Exposure to urban air
  • Hannover, Lower Saxony, Germany
    Fraunhofer ITEM
Sep 12, 2023

Conjunctivitis, Allergic Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.5%),

Completed
  • Conjunctivitis, Allergic
  • Reproxalap Ophthalmic Solution (0.25%)
  • +2 more
  • Mississauga, Ontario, Canada
    Inflamax Research Limited
May 11, 2020

Type I Hypersensitivity Trial in Mississauga (Tree MATA MPL or Tree MATA)

Terminated
  • Type I Hypersensitivity
  • Tree MATA MPL or Tree MATA
  • Mississauga, Ontario, Canada
    Allied Research International Inc.
Nov 26, 2020

Overweight, Physical Inactivity, Healthy Trial in Kuala Lumpur (Low-moderate intensity exercise under normoxia, Low-moderate

Completed
  • Overweight
  • +2 more
  • Low-moderate intensity exercise under normoxia
  • +2 more
  • Kuala Lumpur, Malaysia
    National Sports Institute of Malaysia
Oct 9, 2022

Effect of Game in Increasing Environmental Health Literacy Trial in San Jose, Scotts Valley (SE3 Game)

Enrolling by invitation
  • Effect of Game in Increasing Environmental Health Literacy
  • SE3 Game
  • San Jose, California
  • +1 more
May 16, 2023

Patient Comfort and Environmental Conditions in Carecube

Completed
  • Infectious Diseases
  • Carecube Negative Pressure Isolation Chamber
  • Omaha, Nebraska
    UNMC
Jul 18, 2022

Cardiovascular System, Respiratory System, Cognitive Function Trial in Shanghai (Low temperature (16#) group, Moderate

Not yet recruiting
  • Cardiovascular System
  • +2 more
  • Low temperature (16#) group
  • Moderate temperature (22#) group
  • Shanghai, Shanghai, China
    Department of Environmental Health, School of Public Health, Fud
Oct 3, 2023

Healthy Trial (NIOSH certified N95 personal face covering (mask), Surgical Mask)

Not yet recruiting
  • Healthy
  • NIOSH certified N95 personal face covering (mask)
  • Surgical Mask
  • (no location specified)
Sep 27, 2023

Healthy Trial in San Francisco (Secondhand cannabis emissions/smoke exposure)

Not yet recruiting
  • Healthy
  • Secondhand cannabis emissions/smoke exposure
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
Sep 1, 2023

Rhinitis, Allergic, Seasonal Trial in Shinjuku (ASP4070, Placebo)

Completed
Has Results
  • Rhinitis, Allergic, Seasonal
  • Shinjuku, Tokyo, Japan
    Site JP00001
Jun 16, 2020

Risk Reduction, Environmental Exposure, Risk Behavior, Health Trial in Salt Lake City (Real-Time Exposure Feedback)

Recruiting
  • Risk Reduction
  • +2 more
  • Real-Time Exposure Feedback
  • Salt Lake City, Utah
    University of Utah
Oct 31, 2022

Cardiovascular System, Respiratory System, Cognitive Function Trial in Shanghai (high temperature (32?) group, moderate

Active, not recruiting
  • Cardiovascular System
  • +2 more
  • high temperature (32℃) group
  • moderate temperature (22℃) group
  • Shanghai, Shanghai, China
    Department of Environmental Health, School of Public Health, Fud
Dec 5, 2022

Heat Stress, Heat Exposure, Temperature Change, Body Trial in Ottawa (Humidity-ramp protocol, Above-inflection fixed-condition

Recruiting
  • Heat Stress
  • +3 more
  • Humidity-ramp protocol
  • +3 more
  • Ottawa, Ontario, Canada
    University of Ottawa
Jul 21, 2023